Stock Scorecard
Stock Summary for CVS Health Corp (CVS) - $55.77 as of 11/20/2024 3:56:50 PM EST
Total Score
15 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for CVS
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CVS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CVS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CVS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CVS (71 out of 90)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 6 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 9 |
Latest News for for CVS
Financial Details for CVS
Company Overview |
|
|---|---|
| Ticker | CVS |
| Company Name | CVS Health Corp |
| Country | USA |
| Description | CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island. |
| Sector Name | TRADE & SERVICES |
| Industry Name | RETAIL-DRUG STORES AND PROPRIETARY STORES |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 2/5/2025 |
Stock Price History |
|
| Last Day Price | 55.77 |
| Price 4 Years Ago | 60.55 |
| Last Day Price Updated | 11/20/2024 3:56:50 PM EST |
| Last Day Volume | 12,128,488 |
| Average Daily Volume | 13,531,101 |
| 52-Week High | 79.91 |
| 52-Week Low | 51.61 |
| Last Price to 52 Week Low | 8.06% |
Valuation Measures |
|
| Trailing PE | 14.15 |
| Industry PE | 13.50 |
| Sector PE | 41.04 |
| 5-Year Average PE | 10.51 |
| Free Cash Flow Ratio | 7.25 |
| Industry Free Cash Flow Ratio | 7.30 |
| Sector Free Cash Flow Ratio | 94.88 |
| Current Ratio Most Recent Quarter | 0.80 |
| Total Cash Per Share | 7.69 |
| Book Value Per Share Most Recent Quarter | 59.57 |
| Price to Book Ratio | 0.94 |
| Industry Price to Book Ratio | 0.89 |
| Sector Price to Book Ratio | 9.15 |
| Price to Sales Ratio Twelve Trailing Months | 0.19 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.18 |
| Sector Price to Sales Ratio Twelve Trailing Months | 2.18 |
| Analyst Buy Ratings | 10 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 1,258,410,000 |
| Market Capitalization | 70,181,525,700 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 10/21/2024 |
| Last Dividend Amount | 0.67 |
| Current Dividend Amount | 0.67 |
| Total Years Dividend Increasing | 2 |
| Trailing Annual Dividend Rate | 2.66 |
| Trailing Annual Dividend Yield | 4.77% |
| Forward Annual Dividend Rate | 2.79 |
| Forward Annual Dividend Yield | 5.00% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 2.45% |
| 5-Year Average Dividend Yield | 2.60% |
| 1-Year Dividend Growth Rate Percentage | 10.00% |
| 3-Year Dividend Growth Rate Percentage | 10.00% |
| 5-Year Dividend Growth Rate Percentage | 4.88% |
| All-Time Dividend Growth Rate Percentage | 7.04% |
| Dividend Payout Ratio | 67.51% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -96.10% |
| Annual Earnings Growth | 93.55% |
| Reported EPS 12 Trailing Months | 3.94 |
| Reported EPS Past Year | 4.23 |
| Reported EPS Prior Year | 8.74 |
| Net Income Twelve Trailing Months | 5,016,000,000 |
| Net Income Past Year | 8,344,000,000 |
| Net Income Prior Year | 4,311,000,000 |
| Quarterly Revenue Growth YOY | 6.00% |
| 5-Year Revenue Growth | 12.95% |
| Operating Margin Twelve Trailing Months | 0.02 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 9,680,000,000 |
| Total Cash Past Year | 11,455,000,000 |
| Total Cash Prior Year | 15,723,000,000 |
| Net Cash Position Most Recent Quarter | 9,506,000,000 |
| Net Cash Position Past Year | -109,869,000,000 |
| Long Term Debt Past Year | 121,324,000,000 |
| Long Term Debt Prior Year | 102,776,000,000 |
| Total Debt Most Recent Quarter | 174,000,000 |
| Equity to Debt Ratio Past Year | 0.39 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 76,461,000,000 |
| Total Stockholder Equity Prior Year | 71,469,000,000 |
| Total Stockholder Equity Most Recent Quarter | 74,944,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,687,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.34 |
| Free Cash Flow Past Year | 10,395,000,000 |
| Free Cash Flow Prior Year | 13,450,000,000 |
Options |
|
| Put/Call Ratio | 0.17 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.40 |
| MACD Signal | -1.09 |
| 20-Day Bollinger Lower Band | 52.47 |
| 20-Day Bollinger Middle Band | 58.11 |
| 20-Day Bollinger Upper Band | 63.75 |
| Beta | 0.54 |
| RSI | 39.23 |
| 50-Day SMA | 64.13 |
| 150-Day SMA | 75.37 |
| 200-Day SMA | 75.33 |
System |
|
| Modified | 11/20/2024 10:36:51 PM EST |